 PDL BioPharma, Inc. PDL or the Company Nasdaq: PDLI announces it has entered into a settlement agreement the Settlement Agreement with related entities of Defined Diagnostics, LLC fka Wellstat Diagnostics, LLC Wellstat Diagnostics and, together with such related entities, the Wellstat Parties resolving previously reported litigation relating to loans made to Wellstat Diagnostics by PDL. The loans totaling 44,100,000 were made pursuant to a loan agreement between Wellstat Diagnostics and PDL dated August 2013, and the notes were carried on PDLs balance sheet for 51,391,184 as of June 30, 2020. 